Evidence map›Paper›PMID 31529970›Full record

ArticleBiochemistry2019

Using Tetracysteine-Tagged TDP-43 with a Biarsenical Dye To Monitor Real-Time Trafficking in a Cell Model of Amyotrophic Lateral Sclerosis.

Janice S W Ng, Maya A Hanspal, Naunehal S Matharu, Teresa P Barros, Elin K Esbjörner, Mark R Wilson, Justin J Yerbury, Christopher M Dobson, Janet R Kumita

Open access · hybridAbstract read
In one paragraph

Article in Biochemistry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 3 countries.

Janice S W NgCentre for Misfolding Diseases, Department of Chemistry , University of Cambridge , Lensfield Road , Cambridge CB2 1EW , U.K.
Maya A HanspalCentre for Misfolding Diseases, Department of Chemistry , University of Cambridge , Lensfield Road , Cambridge CB2 1EW , U.K.
Naunehal S MatharuCentre for Misfolding Diseases, Department of Chemistry , University of Cambridge , Lensfield Road , Cambridge CB2 1EW , U.K.
Teresa P BarrosCentre for Misfolding Diseases, Department of Chemistry , University of Cambridge , Lensfield Road , Cambridge CB2 1EW , U.K.
Elin K EsbjörnerDepartment of Biology and Biological Engineering, Division of Chemical Biology , Chalmers University of Technology , Kemivägen 10 , 412 96 Gothenburg , Sweden.ORCID 0000-0002-1253-6342
Mark R WilsonIllawarra Health and Medical Research Institute , Wollongong , NSW 2522 , Australia.
Justin J YerburyIllawarra Health and Medical Research Institute , Wollongong , NSW 2522 , Australia.ORCID 0000-0003-2528-7039
Christopher M DobsonCentre for Misfolding Diseases, Department of Chemistry , University of Cambridge , Lensfield Road , Cambridge CB2 1EW , U.K.
Janet R KumitaCentre for Misfolding Diseases, Department of Chemistry , University of Cambridge , Lensfield Road , Cambridge CB2 1EW , U.K.ORCID 0000-0002-3887-4964
University of Cambridge · GBUniversity of Wollongong · AUChalmers University of Technology · SE

Funding

Wellcome Trust 094425/Z/10/Z
6 · The paper itself

Abstract

TAR DNA-binding protein 43 (TDP-43) has been identified as the major constituent of the proteinaceous inclusions that are characteristic of most forms of amyotrophic lateral sclerosis (ALS) and ubiquitin positive frontotemporal lobar degeneration (FTLD). Wild type TDP-43 inclusions are a pathological hallmark of >95% of patients with sporadic ALS and of the majority of familial ALS cases, and they are also found in a significant proportion of FTLD cases. ALS is the most common form of motor neuron disease, characterized by progressive weakness and muscular wasting, and typically leads to death within a few years of diagnosis. To determine how the translocation and misfolding of TDP-43 contribute to ALS pathogenicity, it is crucial to define the dynamic behavior of this protein within the cellular environment. It is therefore necessary to develop cell models that allow the location of the protein to be defined. We report the use of TDP-43 with a tetracysteine tag for visualization using fluorogenic biarsenical compounds and show that this model displays features of ALS observed in other cell models. We also demonstrate that this labeling procedure enables live-cell imaging of the translocation of the protein from the nucleus into the cytosol.

Indexed as

Models, BiologicalSequence Tagged SitesAmino Acid SequenceAmyotrophic Lateral SclerosisCell Line, TumorCell NucleusCysteineCytosolDNA-Binding ProteinsElectroporationFluoresceinsFluorescent DyesFrontotemporal Lobar DegenerationHumansKineticsOptical Imaging4',5'-bis(1,3,2-dithioarsolan-2-yl)fluoresceinCysteineDNA-Binding ProteinsFluoresceinsFluorescent DyesOrganometallic CompoundsTARDBP protein, human

Identifiers

PMID31529970
PMCPMC6775541
OpenAlexW2971473691

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.